Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application
Open Access
- 6 October 2006
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 14 (1) , 105-116
- https://doi.org/10.1038/sj.cgt.7700991
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasetsNature Genetics, 2006
- BioGRID: a general repository for interaction datasetsNucleic Acids Research, 2006
- A protein interaction network of the malaria parasite Plasmodium falciparumNature, 2005
- Towards a proteome-scale map of the human protein–protein interaction networkNature, 2005
- The MIPS mammalian protein–protein interaction databaseBioinformatics, 2004
- Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapyThe Journal of Gene Medicine, 2004
- Myristoylation-regulated Direct Interaction Between Calcium-bound Calmodulin and N-terminal Region of pp60v-srcJournal of Molecular Biology, 2004
- Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenaseRespirology, 2002
- Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigenJournal of Clinical Investigation, 2000
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990